ITMCTR1900002351RecruitingPhase 1
A multi-center, randomized controlled trial for 'Jia-Wei Si-Ni' decoction in the treatment of ischemic apoplexy based on multi-histology integration strategy
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 80 (—)
- Sex
- All
Inclusion Criteria
- •(1) ischemic stroke patients with a course of 2-4 weeks;
- •(2) aged between 18 and 80 years;
- •(3) meet the diagnostic criteria of cerebral infarction in the guidelines for the diagnosis and treatment of cerebral infarction in China (2017);
- •(4) ischemic stroke that meets the diagnostic criteria of Yang deficiency in traditional Chinese medicine;
- •(5) the patient is conscious;
- •(6) the patient agreed to accept the project and signed the informed consent.
Exclusion Criteria
- •(1) patients with severe heart disease, active liver disease, cardiac insufficiency, renal insufficiency, respiratory failure, malignant tumor and gastrointestinal bleeding may not be able to complete the follow-up;
- •(2) patients with mental illness and deaf-mutes, who have a history of dementia;
- •(3) pregnant and lactating women;
- •(4) patients participating in other clinical trials;
- •(5) patients who are not suitable for clinical trials according to other reasons.
Investigators
Similar Trials
Completed
Not Applicable
A multi-center, randomized, controlled trial on the efficacy and safety of metal stents for biliary drainage prior to pancreatic cancer surgerypancreatic cancerJPRN-UMIN000032076Juntendo University200
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Unknown
Phase 4
A multicenter, randomized controlled trial of entecavir treatment for the patients with hepatocellular carcinoma complicated with chronic hepatitis B or cirrhosis after a curative treatment of the cancer: Anti-virus effect, influence on hepatic reserve, cancer recurrence, and survival.Chronic hepatitis B and cirrhosis after a curative treatment of hepatocellular carcinomaJPRN-UMIN000000597Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences170
Recruiting
Phase 3
Australasian Resuscitation In Sepsis Evaluation Randomised Controlled TrialACTRN12608000053325Australian and New Zealand Intensive Care Research Centre1,600
Recruiting
Phase 1
A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategysevere novel coronavirus pneumonia (COVID-19)ITMCTR2000003002Huangshi Hospital of Traditional Chinese Medicine